ALB and neoplasm: Compared with the control group, the tumor inhibitory rate (TIR) of DOX was ca. 7.2%, HSA-DOX was ca. 21.5%, three-agent combination was ca. 24.6%, and the HSA–NAMI-A–Cu(BpT)Br–DOX complex was ca. 44.8%.